These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22323674)

  • 1. Postmenopausal vaginal bleeding in women using hormone replacement therapy.
    Burbos N; Musonda P; Duncan TJ; Crocker SG; Nieto JJ; Morris EP
    Menopause Int; 2012 Mar; 18(1):5-9. PubMed ID: 22323674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of investigations for postmenopausal vaginal bleeding in women under the age of 50 years.
    Burbos N; Musonda P; Crocker SG; Morris EP; Duncan TJ; Nieto JJ
    Gynecol Oncol; 2012 Apr; 125(1):120-3. PubMed ID: 22233690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related differential diagnosis of vaginal bleeding in postmenopausal women: a series of 3047 symptomatic postmenopausal women.
    Burbos N; Musonda P; Giarenis I; Shiner AM; Giamougiannis P; Morris E; Nieto JJ
    Menopause Int; 2010 Mar; 16(1):5-8. PubMed ID: 20424279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of postmenopausal women with vaginal bleeding when the endometrium can not be visualized.
    Burbos N; Musonda P; Crocker SG; Morris EP; Nieto JJ; Duncan TJ
    Acta Obstet Gynecol Scand; 2012 Jun; 91(6):686-91. PubMed ID: 22443120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial cancer rate in Hormone replacement therapy users with postmenopausal bleeding: Retrospective cohort study.
    Buchanan C; Robinson M; Macdonald MC
    Post Reprod Health; 2022 Sep; 28(3):143-148. PubMed ID: 35976770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V; Bull D; Reeves G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing postmenopausal bleeding revisited: what is the best first line investigation and who should be seen within 2 weeks? A cross-sectional study of 326 women.
    Ewies AA; Musonda P
    Eur J Obstet Gynecol Reprod Biol; 2010 Nov; 153(1):67-71. PubMed ID: 20650562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal uterine bleeding on hormone replacement: the importance of intrauterine structural abnormalities.
    Akkad AA; Habiba MA; Ismail N; Abrams K; al-Azzawi F
    Obstet Gynecol; 1995 Sep; 86(3):330-4. PubMed ID: 7651636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disturbances of endometrial bleeding with hormone replacement therapy.
    Thomas AM; Hickey M; Fraser IS
    Hum Reprod; 2000 Aug; 15 Suppl 3():7-17. PubMed ID: 11041216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal replacement therapy and evaluation of intrauterine pathology in postmenopausal women: a ten-year study.
    Mossa B; Imperato F; Marziani R; Perniola F; Melluso J; Perniola G; Napolitano C
    Eur J Gynaecol Oncol; 2003; 24(6):507-12. PubMed ID: 14658591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical inquiries. What is the best diagnostic approach to postmenopausal vaginal bleeding in women taking hormone replacement therapy?
    Kerns JW; Mabry S; Lopez R
    J Fam Pract; 2001 Oct; 50(10):843-4. PubMed ID: 11674884
    [No Abstract]   [Full Text] [Related]  

  • 12. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
    Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
    Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the performance of two clinical models in estimating the risk of endometrial cancer in symptomatic postmenopausal women.
    Musonda P; Burbos N; Duncan TJ; Crocker SG; Morris EP; Nieto JJ
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):433-8. PubMed ID: 21975177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial response to raloxifene compared with placebo, cyclical hormone replacement therapy, and unopposed estrogen in postmenopausal women.
    Davies GC; Huster WJ; Shen W; Mitlak B; Plouffe L; Shah A; Cohen FJ
    Menopause; 1999; 6(3):188-95. PubMed ID: 10486787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial expression of steroid receptors in postmenopausal hormone replacement therapy users: relationship to bleeding patterns.
    Vani S; Critchley HO; Fraser IS; Hickey M
    J Fam Plann Reprod Health Care; 2008 Jan; 34(1):27-34. PubMed ID: 18201403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to HRT.
    McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
    Maturitas; 2006 Mar; 53(4):454-61. PubMed ID: 16169691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hysteroscopy in women with abnormal uterine bleeding on hormone replacement therapy: a comparison with postmenopausal bleeding.
    Nagele F; O'Connor H; Baskett TF; Davies A; Mohammed H; Magos AL
    Fertil Steril; 1996 Jun; 65(6):1145-50. PubMed ID: 8641488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of outpatient hysteroscopy in diagnosing endometrial pathology in postmenopausal women with and without hormone replacement therapy.
    Elliott J; Connor ME; Lashen H
    Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1112-9. PubMed ID: 14616256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women with recurrent postmenopausal bleeding should be re-investigated but are not more likely to have endometrial cancer.
    Ronghe R; Gaudoin M
    Menopause Int; 2010 Mar; 16(1):9-11. PubMed ID: 20424280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.